← Back to catalogue

Intravenous Infusion Starter Set

FDA UDI

Class II (US FDA UDI)

by Safeguard Us Operating, Llc

Identity

Trade Name
INTRAVENOUS INFUSION STARTER SET FDA UDI
Generic Name
Intraosseous infusion kit FDA UDI
Device Name
18 GA Catheter 1 ea 20 GA Catheter 1 ea Saline Flush (5cc pre-filled syringe) 1 ea Povidone Prep Pad 1 ea Alcohol Prep Pad 2 ea IV Administration Set 1 ea Needle Free Valve with Luer Lock 1 ea Constricting Band 1 ea IV Catheter Dressing 1 ea Transparent Film Dressing 1 ea 2"x2" Gauze Pad (2 pack) 1 ea FDA UDI
Model / Reference
05 FDA UDI
Description
18 GA Catheter 1 ea 20 GA Catheter 1 ea Saline Flush (5cc pre-filled syringe) 1 ea Povidone Prep Pad 1 ea Alcohol Prep Pad 2 ea IV Administration Set 1 ea Needle Free Valve with Luer Lock 1 ea Constricting Band 1 ea IV Catheter Dressing 1 ea Transparent Film Dressing 1 ea 2"x2" Gauze Pad (2 pack) 1 ea FDA UDI

Identifiers

Catalog Number
80-100 FDA UDI
Primary DI / UDI-DI
M68980100050 FDA UDI
FDA Product Code
LRS FDA UDI
GMDN Term
Intraosseous infusion kit FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
880.5200 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Intravenous Infusion Starter Set by Safeguard Us Operating, Llc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 0c9b7e93-0e24-45ca-ae21-9b331fae5a27 36 fields · synced May 30, 2026